• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BLUEMERCURY ANNOUNCES DR. ELYSE LOVE AS DERMATOLOGIST ADVISOR

    8/1/22 8:58:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary
    Get the next $M alert in real time by email

    WASHINGTON, Aug. 1, 2022 /PRNewswire/ -- Bluemercury announced today the appointment of Dr. Elyse Love as the retailer's first Dermatologist Advisor. Dr. Love is a board-certified dermatologist who practices a wide spectrum of medical and cosmetic dermatology at Gramercy Laser and Medical Dermatology (GLAMDerm) in NYC. 

    Dr. Elyse Love, Bluemercury Dermatologist Advisor

    Founded with the goal of creating a more personal beauty shopping experience, Bluemercury has maintained its position as the neighborhood beauty store where customers can find best-in-class, innovative beauty products with honest, expert advice in a welcoming and friendly setting. Dr. Love's appointment is a natural step in the retailer's ongoing effort to cater to the personalized needs of their customers, with education and expertise at the core.

    "We are thrilled to welcome Dr. Elyse Love to the Bluemercury family," said Maly Bernstein, Chief Executive Officer at Bluemercury. "As we all know, today's beauty consumer is increasingly more educated and thoughtful about their purchase decisions. Dr. Love's expert perspective and credibility will be invaluable in strengthening our position as the ultimate beauty resource with the best products, services and professionals that shoppers can trust."

    In her new role, Dr. Love will collaborate with Bluemercury to offer expert guidance on the retailer's current and future product portfolio, as well as its strategy surrounding spa services. Additionally, she will help propel internal education by assisting in the development of product training materials for Bluemercury's in-store Beauty Experts and estheticians.

    Dr. Love will also be integrated into external communications efforts including email marketing, social media and Bluemercury's ongoing virtual #Masterclass series on Bluemercury.com.

    "From the moment I first stepped into a Bluemercury store, I was immediately impressed with the curated product selection and the seamless, straightforward shopping experience," said Dr. Love. "I'm honored to join the team in this advisory role and look forward to bringing my knowledge and passion for beauty and skincare to the world of Bluemercury."

    For additional information on Bluemercury, visit www.Bluemercury.com.

    ABOUT BLUEMERCURY

    Bluemercury is widely recognized as the nation's largest and fastest-growing luxury beauty products and retail spa chain. Bluemercury was created as a haven for beauty lovers—a place for them to receive honest, expert advice and to find the best beauty products in the world, right in their neighborhoods. Bluemercury joined Macy's, Inc. (NYSE:M) through acquisition in March 2015. The retailer now boasts more than 180 specialty stores nationwide. For more information or to become a member of BLUEREWARDS, visit www.bluemercury.com and follow @bluemercury on social media.

    ABOUT DR. ELYSE LOVE

    Dr. Love is a board-certified dermatologist practicing medical and cosmetic dermatology at Gramercy Laser and Medical Dermatology (GLAMDerm) in NYC. She treats a wide spectrum of ages, genders, races, and ethnicities in her practice. Her signature approach is designing routines that fit each individual by combining lifestyle modifications, over the counter and prescription products, and minimally invasive procedures into an approachable, enjoyable, and effective routine.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bluemercury-announces-dr-elyse-love-as-dermatologist-advisor-301596761.html

    SOURCE Bluemercury

    Get the next $M alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $M

    DatePrice TargetRatingAnalyst
    1/14/2026$27.00Buy
    Jefferies
    12/10/2025Neutral
    Guggenheim
    12/4/2025$22.00 → $25.00Market Perform
    Telsey Advisory Group
    11/28/2025$17.00 → $22.00Market Perform
    Telsey Advisory Group
    10/15/2025Neutral
    BTIG Research
    9/4/2025$14.00 → $17.00Market Perform
    Telsey Advisory Group
    5/29/2025$15.00 → $14.00Market Perform
    Telsey Advisory Group
    4/28/2025$12.00Equal Weight
    Barclays
    More analyst ratings

    $M
    SEC Filings

    View All

    Macy's Inc filed SEC Form 8-K: Leadership Update

    8-K - Macy's, Inc. (0000794367) (Filer)

    12/12/25 4:41:34 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 10-Q filed by Macy's Inc

    10-Q - Macy's, Inc. (0000794367) (Filer)

    12/10/25 4:30:37 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Amendment: Macy's Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K/A - Macy's, Inc. (0000794367) (Filer)

    12/3/25 12:57:27 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    $M
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Macy's with a new price target

    Jefferies resumed coverage of Macy's with a rating of Buy and set a new price target of $27.00

    1/14/26 8:43:49 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Guggenheim initiated coverage on Macy's

    Guggenheim initiated coverage of Macy's with a rating of Neutral

    12/10/25 8:28:24 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Macy's with a new price target

    Telsey Advisory Group reiterated coverage of Macy's with a rating of Market Perform and set a new price target of $25.00 from $22.00 previously

    12/4/25 8:13:20 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    $M
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BLOOMINGDALE'S DEBUTS LATEST CAROUSEL SHOP: BLOOMINGDALE'S X "WUTHERING HEIGHTS"

    The new carousel shop, unveiled in partnership with Warner Bros. Discovery is inspired by the cinematic reimagining of "Wuthering Heights", featuring romantic gifts, exclusive sweet treats, immersive events, and an obsession-worthy AQUA collaboration. NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Bloomingdale's announces a partnership with Warner Bros. Discovery to celebrate the much-anticipated Valentine's release of the feature film "Wuthering Heights". Running from January 15 through February 22, Bloomingdale's X "Wuthering Heights" transforms the 59th Street Carousel into a gothic, romantic world inspired by the film. Customers can shop an exclusive AQUA collaboration as well as a multitude of

    1/15/26 9:00:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Macy's, Inc. Reports Third Quarter 2025 Results

    Macy's, Inc. net sales and Adjusted diluted EPS exceeded guidance, driven by Bold New Chapter momentum Macy's, Inc. delivered its strongest comparable sales1 growth in 13 quarters Macy's go-forward business achieved its second consecutive quarter of comparable sales growth, fueled by Reimagine 125 stores and digital strength Bloomingdale's achieved its fifth consecutive quarter of comparable sales growth Macy's, Inc. (NYSE:M) today reported financial results for the third quarter of 2025 and updated its annual guidance. Third Quarter Highlights Macy's, Inc. achieved net sales of $4.7 billion, exceeding the company's guidance range. Macy's, Inc. reported comparable sales up 2.5% on

    12/3/25 6:55:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    NYSE Content Advisory: Pre-Market Update + Santa Rings Opening Bell Ahead of 99th Macy's Thanksgiving Day Parade

    NEW YORK, Nov. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on November 26th The Dow extended its winning streak to three days on Tuesday, jumping over 650 points on optimism for another rate cut. AI enthusiasm lifted the S&P 500 nearly 1%, while Alphabet hit a record high amid reports of AI chip talks with Meta.Despite recent gains, the S&P 500 is down about 1.1% for November, and the Dow has slipped roughly 1%. Markets close Thursday for Thanks

    11/26/25 8:55:00 AM ET
    $ICE
    $M
    Investment Bankers/Brokers/Service
    Finance
    Department/Specialty Retail Stores
    Consumer Discretionary

    $M
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sesler Douglas William

    4 - Macy's, Inc. (0000794367) (Issuer)

    1/5/26 4:27:03 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 4 filed by Director Markee Richard L

    4 - Macy's, Inc. (0000794367) (Issuer)

    1/5/26 4:25:35 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 4 filed by Director Clark Richard

    4 - Macy's, Inc. (0000794367) (Issuer)

    1/5/26 4:24:17 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    $M
    Financials

    Live finance-specific insights

    View All

    Macy's, Inc. Reports Third Quarter 2025 Results

    Macy's, Inc. net sales and Adjusted diluted EPS exceeded guidance, driven by Bold New Chapter momentum Macy's, Inc. delivered its strongest comparable sales1 growth in 13 quarters Macy's go-forward business achieved its second consecutive quarter of comparable sales growth, fueled by Reimagine 125 stores and digital strength Bloomingdale's achieved its fifth consecutive quarter of comparable sales growth Macy's, Inc. (NYSE:M) today reported financial results for the third quarter of 2025 and updated its annual guidance. Third Quarter Highlights Macy's, Inc. achieved net sales of $4.7 billion, exceeding the company's guidance range. Macy's, Inc. reported comparable sales up 2.5% on

    12/3/25 6:55:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Macy's, Inc. to Report Third Quarter 2025 Results on December 3, 2025

    Macy's, Inc. (NYSE:M) will report its third quarter 2025 sales and earnings results on Wednesday, December 3. The company will host a call and webcast with financial analysts and investors at 8:00 a.m. ET. The call will be hosted by Macy's, Inc.'s Chairman and Chief Executive Officer Tony Spring and Chief Operating Officer and Chief Financial Officer Tom Edwards. The general public and the media will be able to access the live webcast and associated presentation via the company's website at www.macysinc.com. To participate in the call, analysts and investors may call 1-877-407-0832. A replay of the conference call will be available on the company's website or by calling 1-877-660-6853,

    11/13/25 4:15:00 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Macy's, Inc. Board of Directors Declares Quarterly Dividend

    The board of directors of Macy's, Inc. (NYSE:M) today declared a regular quarterly dividend of 18.24 cents per share on Macy's, Inc.'s common stock, payable on January 2, 2026, to shareholders of record at the close of business on December 15, 2025. About Macy's, Inc. Macy's, Inc. (NYSE:M) is a trusted source for quality brands through our iconic nameplates – Macy's, Bloomingdale's and Bluemercury. Headquartered in New York City, our comprehensive digital and nationwide footprint empowers us to deliver a seamless shopping experience for our customers. For more information, visit macysinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20251024509240

    10/24/25 1:11:00 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    $M
    Leadership Updates

    Live Leadership Updates

    View All

    Macy's, Inc. Announces Evolution of Leadership Team

    Seasoned retail executive Thomas J. Edwards to join Macy's, Inc. as Chief Operating Officer and Chief Financial Officer Reiterates first quarter 2025 guidance Macy's, Inc. (NYSE:M) today announced the evolution of its executive leadership team and structure to further advance the company's "Bold New Chapter" strategy that is designed to return the company to long-term profitable growth. Thomas J. Edwards will become Chief Operating Officer and Chief Financial Officer at Macy's, Inc., effective June 22nd Barbie Cameron, Macy's Chief Stores Officer, will report directly to Chairman and Chief Executive Officer, Tony Spring, effective June 22nd Maly Bernstein, CEO Bluemercury, will repo

    4/1/25 9:00:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Macy's, Inc. Appoints Robert Chavez to Board of Directors

    Macy's, Inc. (NYSE:M) today announced the appointment of a new independent director, Robert Chavez, to its Board of Directors (the "Board"), effective April 1, 2025. Chavez has spent the entirety of his more than 45-year career in the retail industry, with a focus on the luxury space. He most recently served for 24 years as President and Chief Executive Officer of Hermès Americas, a division of Hermès International Société, where he oversaw operations in the U.S., Canada and Latin America, which included growing the e-commerce business, expanding product offerings and adding new stores to the brand's portfolio. Previously, he served for eight years as the Chief Executive Officer of Etienn

    1/6/25 8:00:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    BLOOMINGDALE'S LAUNCHES "CAMP BLOOMINGDALE'S"

    The newest Carousel @ Bloomingdale's offers shoppers a sentimental one-stop-shop for summer must-haves NEW YORK, April 11, 2024 /PRNewswire/ -- Bloomingdale's today announces the launch of its latest Carousel: Camp Bloomingdale's. The pop-up space will transform into the ultimate summer destination for all ages, complete with a wide assortment of multicategory must-haves including swimwear, accessories, beauty, food, beverage favorites, and so much more. For the first time, Bloomingdale's will welcome Coleman, the experts in outdoor gear and equipment, offering an array of campsite essentials.

    4/11/24 12:21:00 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    $M
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Macy's Inc

    SC 13G - Macy's, Inc. (0000794367) (Subject)

    10/31/24 11:55:01 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form SC 13G/A filed by Macy's Inc (Amendment)

    SC 13G/A - Macy's, Inc. (0000794367) (Subject)

    2/13/24 5:08:05 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form SC 13G/A filed by Macy's Inc (Amendment)

    SC 13G/A - Macy's, Inc. (0000794367) (Subject)

    2/9/23 11:25:11 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary